You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Hi, while reading the paper, I came up with some questions.
1 - As you mentioned in Section 6.2, "MVFA’s advantage lies in its ability to effectively utilize a few abnormal samples", does that mean MVFA is not capable of "few-normal-shot" setting?
2 - How did you measure performance of WinCLIP model when the authors did not release their official code? Did you reimplemented the code yourself(or team) or use unofficial implementation?
3 - In Table 3 in-domain (MVTec) part, are the AUC scores of MVFA averaged over 5 random seeds like WinCLIP and April-GAN?
Thank you in advance!
The text was updated successfully, but these errors were encountered:
choi-jiwoo
changed the title
Some questions on table 1 result
Some questions on model evaluation results
Jul 5, 2024
Hi, while reading the paper, I came up with some questions.
1 - As you mentioned in Section 6.2, "MVFA’s advantage lies in its ability to effectively utilize a few abnormal samples", does that mean MVFA is not capable of "few-normal-shot" setting?
2 - How did you measure performance of WinCLIP model when the authors did not release their official code? Did you reimplemented the code yourself(or team) or use unofficial implementation?
3 - In Table 3 in-domain (MVTec) part, are the AUC scores of MVFA averaged over 5 random seeds like WinCLIP and April-GAN?
Thank you in advance!
The text was updated successfully, but these errors were encountered: